These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21851400)

  • 1. Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients?
    Vukelic V; Peixoto AJ
    Semin Dial; 2011; 24(4):400-2. PubMed ID: 21851400
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
    Mark PB; Petrie CJ; Jardine AG
    Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
    Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
    Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients.
    Granja CA; Tailor PT; Gorban-Brennan N; Francis J; Bekui A; Finkelstein FO
    Adv Perit Dial; 2007; 23():155-60. PubMed ID: 17886624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratio.
    Jacobs LH; Mingels AM; Wodzig WK; van Dieijen-Visser MP; Kooman JP
    Am J Clin Pathol; 2010 Sep; 134(3):516-7; author reply 517. PubMed ID: 20716809
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
    Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP
    Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients.
    Taskapan MC; Taskapan H; Ulutas O; Orhan M; Sahin I
    Ren Fail; 2007; 29(2):221-5. PubMed ID: 17365940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
    Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
    Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
    Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
    Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.